Prospeo
Hero Section BackgroundHero Section Background
Santhera Pharmaceuticals

Santhera Pharmaceuticals Email Formats

Pharmaceutical ManufacturingFlag of CHPratteln, Basel-Country, Switzerland101-200 Employees

Santhera Pharmaceuticals Email Formats

Santhera Pharmaceuticals uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@santhera.com), used 48.8% of the time.

FormatExamplePercentage
{first initial}.{last name}
j.doe@santhera.com
48.8%
{first name}.{last name}
john.doe@santhera.com
42.5%
{last name}{last name}
doedoe@santhera.com
5%
{last name}{first initial}
doej@santhera.com
3.8%

Key Contacts at Santhera Pharmaceuticals

Flag of CH

Nathalie Zeiri

CEO Assistant / Board Management Support

Flag of CH

Marc Schrader

Chief Technology Officer

Flag of DE

Heike Lah

Head of Sales and Marketing Germany / Austria

Company overview

HeadquartersHohenrainstrasse 24, Pratteln, Basel-Country 4133, CH
Phone number+41619068950
Website
NAICS3254
SIC283
Founded2004
Employees101-200
Socials

About Santhera Pharmaceuticals

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the Food and Drug Administration (FDA), in the EU by the European Medicines Agency (EMA), and in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA). Santhera has out-licensed rights to AGAMREE for North America to Catalyst Pharmaceuticals, Inc. and for China to Sperogenix Therapeutics. For more information, please visit the Company's website at www.santhera.com

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Manager
Entry
Head

Employees by Department

Santhera Pharmaceuticals has 59 employees across 12 departments.

Departments

Number of employees

Funding Data

Explore Santhera Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-02-1014$5,400,000
2024-07-1816$78,000,000
2025-10-2316$25,200,000

Funding Insights

$108,600,000

Total funding amount

$25,200,000

Most recent funding amount

3

Number of funding rounds

Santhera Pharmaceuticals Tech Stack

Discover the technologies and tools that power Santhera Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

jQuery

jQuery

JavaScript libraries

Google Tag Manager

Google Tag Manager

Tag managers

Nginx

Nginx

Reverse proxies

PHP

PHP

Programming languages

Yii

Yii

Web frameworks

Google Font API

Google Font API

Font scripts

Google Analytics

Google Analytics

Analytics

Craft CMS

Craft CMS

CMS

Microsoft 365

Microsoft 365

Email

Frequently asked questions

Santhera Pharmaceuticals is located in Pratteln, Basel-Country, CH.
You can reach Santhera Pharmaceuticals at +41619068950.
Santhera Pharmaceuticals was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.
Santhera Pharmaceuticals has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.
Santhera Pharmaceuticals has raised a total of $108,600,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles